A collection of monoclonal antibodies (MAbs) against the haemagglutinin—neuraminidase (HN) and fusion (F) glycoproteins of parainfluenza virus type 3 (PIV3) was used for passive immunization of intracerebrally infected newborn hamsters. A significant degree of protection was obtained with MAbs against both the HN and F viral proteins, but no individual antibody conferred complete protection against disease. MAbs against different epitopes provided different degrees of protection. A MAb to the Sendai virus HN protein was found to confer protection against PIV3 brain infection.
ALSHEIKHLYA.-R., öRVELLC, ANDERSSONT., PERLMANNP.1985; The role of serologically defined epitopes on mumps virus HN-glycoprotein in the induction of virus dependent cytotoxicity (VDCC). Analysis with monoclonal antibodies. Scandinavian Journal of Immunology 22:529–538
CHANOCKR. M., PARROTTR. H., COOKK., ANDREWSB. E., BELLJ. A., REICHELDERFERT., KAPIKIANA. Z., MASTROTAF. M., HUEBNERR. J.1958; Newly recognized myxoviruses from children with respiratory disease. New England Journal of Medicine 258:207–213
FULGINITIV. A., ELLERJ. J., DOWNIEA. W., KEMPEC. H.1967; Altered reactivity to measles virus. Atypical measles in children previously immunized with inactivated measles virus vaccines. Journal of the American Medical Association 202:1075–1080
KINGSBURYD. W., BRATTM. A., CHOPPINP. W., HANSONR. P., HOSAKAY., TER MEULENV., NORRBYE., PLOWRIGHTW., ROTTR., WUNNERW. H.1978; Paramyxoviridae. Intervirology 10:137–152
LEFRANCOISL.1984; Protection against lethal viral infection by neutralizing and non-neutralizing monoclonal antibodies: distinct mechanisms of action in vivo. Journal of Virology 51:208–214
LOVEA., MALMG., RYDBECKR., NORRBYE., KRISTENSSONK.1985a; Developmental disturbances in the hamster retina caused by a mutant of mumps virus. Developmental Neuroscience 7:65–72
LOVEA., RYDBECKR., KRISTENSSONK., öRVELLC., NORRBYE.1985b; Hemagglutinin-neuraminidase glycoprotein as determinant of pathogenicity in mumps virus hamster encephalitis: analysis of mutants selected with monoclonal antibodies. Journal of Virology 53:67–74
LOVEA., RYDBECKR., LJUNGDAHLÅ., KRISTENSSONK., NORRBYE.1986a; Selection of mutants of mumps virus with altered structure and pathogenicity by passage in vivo. Microbial Pathogenesis 1:149–158
LOVEA., RYDBECKR., UTTERG., öRVELLC, KRISTENSSONK., NORRBYE.1986b; Monoclonal antibodies against the fusion protein are protective in necrotizing mumps meningoencephalitis. Journal of Virology 58:220–222
MOREINB., SHARPM., SUNDQUISTB., SIMONSK.1983; Protein subunit vaccines of parainfluenza type 3 virus: immunogenic effect in lambs and mice. Journal of General Virology 64:1557–1569
MDCHMOREH. G., PARKINSONA. J., HUMPHRIESJ. E., SCOTTN. E., MCINTOSHD. A., SCOTTL. V., OOONEYM. K., MILESJ. A. R.1981; Persistent parainfluenza virus shedding during isolation at the South Pole. Nature, London 289:187–189
NORRBYE., ENDERS-RUCKLEG., TER MEULENV.1975; Differences in the appearance of antibodies to structural components of measles virus after immunization with inactivated and live virus. Journal of Infectious Diseases 132:262–269
öRVELLC., GRANDIENM.1982; The effects of monoclonal antibodies on biologic activities of structural proteins of Sendai Virus. Journal of Immunology 129:2779–2787
öRVELLC, RYDBECKR., LOVEA.1986; Immunological relationships between mumps virus and parainfluenza viruses studied with monoclonal antibodies. Journal of General Virology 67:1929–1939
RAMMOHANK., MCFARLANDH. F., MCFARLLND. E.1981; Induction of subacute murine measles encephalitis by monoclonal antibody to virus hemagglutinin. Nature, London 290:588–589
RAYR., BROWNV. E., COMPANSR. W.1985; Glycoproteins of human parainfluenza virus type 3: characterization and evaluation as a subunit vaccine. Journal of Infectious Diseases 152:1219–1230
RUSSELLP. H.1986; The synergistic neutralization of Newcastle disease virus by two monoclonal antibodies to its haemagglutinin-neuraminidase protein. Archives of Virology 90:135–144
RYDBECKR., öRVELLC, LöVEA., NORRBYE.1986; Characterization of four parainfluenza virus type 3 proteins by use of monoclonal antibodies. Journal of General Virology 67:1531–1542
RYDBECKR., LOVEA., ÖRVELLC., NORRBYE.1987; Antigenic analysis of human and bovine parainfluenza virus type 3 strains with monoclonal antibodies. Journal of General Virology 68:2153–2160
SCHMALJOHNA. L., JOHNSONE. D., DALRYMPLEJ. M., COLEC. A.1982; Non-neutralizing monoclonal antibodies can prevent lethal alphavirus encephalitis. Nature, London 297:70–72
SHIBUTAH., KANDAT., NOZAWAA., SATOS., KUMANISHIT.1985; Experimental parainfluenza virus infection in mice: growth and spread of a highly pathogenic variant of parainfluenza 3 virus in the mouse brain. Archives of Virology 83:43–52
WOLINSKYJ. S., WAXHAMM. N., SERVERA. C.1985; Protective effects of glycoprotein-specific monoclonal antibodies on the course of experimental mumps virus meningoencephalitis. Journal of Virology 53:727–734
YEWDELLJ., GERHARDW.1982; Delineation of four antigenic sites on a paramyxovirus glycoprotein via which monoclonal antibodies mediate distinct antiviral activities. Journal of Immunology 128:2670–2675